Including the acquisition and expansion of the manufacturing facility, Eli Lilly will be investing $4bn in the site. After ...
“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...
Novocure's PANOVA-3 trial shows TTFields therapy with chemotherapy improves survival in pancreatic cancer, marking a ...
As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...
Radiopharmaceuticals have also been the target of large partnership deals, including a recent $140 million partnership ...
Discover how a strategic acquisition in pharma packaging is set to drive growth as the market aims to double by 2028 ...
The potential $2.9 billion deal stands the New Jersey company in good stead after recent disappointing results in its ALS ...
The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational ...
The Portuguese contract development and manufacturing organization (CDMO) Hovione continues its spray drying expansion with ...